Przejdź do zawartości
Merck

[Yimusake alone or combined with trazodone hydrochloride for primary premature ejaculation].

Zhonghua nan ke xue = National journal of andrology (2012-05-12)
Ji-Xiu Xu, Guo Gao, Ning Xu, Yun-Yun Yang
ABSTRAKT

To study the clinical effects of the Chinese drug Yimusake, used alone or in combination with trazodone hydrochloride, on primary premature ejaculation (PE). Sixty-eight primary PE patients were randomized to a control (n=32) and an experimental group (n=36), the former treated with Yimusake 1 tablet (50 mg) pre day, and the latter with 1 tablet of trazodone hydrochloride (50 mg) pre day in addition, both given orally after supper and for 4 weeks, followed by observation of the therapeutic effects. Eighteen cases (56.25%) responded in the control and 25 (69.44% ) in the experimental group, with statistically significant difference between the two groups (P<0.05). Yimusake combined with trazodone hydrochloride is highly efficacious for primary PE.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Sigma-Aldrich
Trazodone hydrochloride, ≥99% (HPLC), powder
Supelco
Trazodone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®